Similarly, we confirmed that 10 nM bortezomib increased the expression of NKG2D and DNAM-1 ligands on MM cells and had little effect on the viability of fresh (Figure S1) and induced NK and γδ T cells in vitro. The gene discussed is KLRK1; the disease is Miyoshi myopathy.